CHRONIC MYELOGENOUS LEUKEMIA, ACCELERATED PHASE

Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA, ACCELERATED PHASE explained in plain language.

Never miss a new study

Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA, ACCELERATED PHASE trials appear

Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA, ACCELERATED PHASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug hope to stop dangerous transplant complication in kids

Disease control Ongoing

This study is testing if adding a drug called vorinostat to standard medications can better prevent graft-versus-host disease (GVHD) in children and young adults getting a bone marrow transplant for blood cancers. GVHD is a serious complication where the donor's immune cells atta…

Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA, ACCELERATED PHASE

Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

CHRONIC MYELOGENOUS LEUKEMIA, ACCELERATED PHASE

Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA, ACCELERATED PHASE trials appear

New drug hope to stop dangerous transplant complication in kids